an ocular disorder treatment implant includes an anchor and a therapeutic agent . the implant has a body with first and second end portions . the implant is configured to transport fluid from the anterior chamber of an eye to a physiological outflow pathway of the eye . the body has at least one inlet opening at the first end portion and at least one outlet opening at the second end portion such that the inlet and outlet openings are in fluid communication and define an axis therebetween . the anchor extends substantially perpendicularly to a part of the axis between the openings , and at least one outlet opening is configured to be positioned in the physiological outflow pathway . one implant has two outlet openings , and the anchor is disposed closer to one of the outlet openings .